Research supports its role in promoting fat oxidation and improving metabolic flexibility, offering a practical option for those pursuing meaningful body recomposition without injections
They are molecularly intermediate between small molecules and macromolecules, but have sufficient biochemical and therapeutic differences
Key Biomarkers and Clinical Indicators for This Combination Before considering metformin and semaglutide together, understanding relevant biomarkers can inform provider decision-making
10.2478/acph-2019-0045 129 MalhotraD.Portales-CasamarE.SinghA.SrivastavaS.ArenillasD.HappelC.et al (2010)
You can read the abstract at Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial A group of researchers conducted a phase 3 clinical trial to examine the efficacy and safety of subcutaneous semaglutide 2.4 mg once per week, semaglutide 1.0 mg (licensed for the treatment of diabetes), and placebo in managing weight in an adult population who were overweight or obese and have type 2 diabetes
Collaborative decision-making between patients and their healthcare team ensures optimal outcomes for both physical and mental health
